statistiche ricercatore

Continente	#
NA - Nord America	859
EU - Europa	670
AS - Asia	373
SA - Sud America	100
AF - Africa	5
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.008

Nazione	#
US - Stati Uniti d'America	849
RU - Federazione Russa	182
GB - Regno Unito	124
CN - Cina	123
IE - Irlanda	109
SG - Singapore	99
BR - Brasile	82
IT - Italia	76
VN - Vietnam	63
SE - Svezia	44
UA - Ucraina	30
DE - Germania	28
HK - Hong Kong	23
FR - Francia	21
FI - Finlandia	19
KR - Corea	15
BE - Belgio	11
IN - India	9
AR - Argentina	7
CA - Canada	7
TR - Turchia	7
AT - Austria	5
ID - Indonesia	5
JP - Giappone	5
NL - Olanda	4
PY - Paraguay	4
AZ - Azerbaigian	3
BD - Bangladesh	3
CZ - Repubblica Ceca	3
EC - Ecuador	3
ES - Italia	3
KZ - Kazakistan	3
PL - Polonia	3
SA - Arabia Saudita	3
CH - Svizzera	2
CO - Colombia	2
EG - Egitto	2
MX - Messico	2
PK - Pakistan	2
UZ - Uzbekistan	2
ZA - Sudafrica	2
A2 - ???statistics.table.value.countryCode.A2???	1
AE - Emirati Arabi Uniti	1
AL - Albania	1
BA - Bosnia-Erzegovina	1
CR - Costa Rica	1
GR - Grecia	1
HR - Croazia	1
IL - Israele	1
IR - Iran	1
LB - Libano	1
LT - Lituania	1
MA - Marocco	1
MY - Malesia	1
NO - Norvegia	1
NP - Nepal	1
PE - Perù	1
TH - Thailandia	1
TW - Taiwan	1
UY - Uruguay	1
Totale	2.008

Nome	#
Molecular insights to the bioactive form of BV02, a reference inhibitor of 14-3-3σ protein-protein interactions	266
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections	261
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform	243
Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs	239
Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity	236
Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors	212
Development of flavonol and flavanone derivatives as anti-trypanosomatidic drugs	188
Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases	141
Crystal structure of the ternary complex of Leishmania major pteridine reductase 1 with the cofactor NADP+/NADPH and the substrate folic acid	136
Multitarget, selective compound design yields potent inhibitors of a Kinetoplastid Pteridine Reductase 1	134
Totale	2.056

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	119	0	0	0	0	0	20	5	21	10	20	9	34
2021/2022	127	4	19	9	14	11	4	6	6	8	10	11	25
2022/2023	148	8	11	23	11	17	34	5	12	17	2	6	2
2023/2024	192	7	7	16	13	9	52	60	1	3	7	0	17
2024/2025	306	10	13	29	14	36	27	9	10	33	12	35	78
2025/2026	627	60	129	119	151	165	3	0	0	0	0	0	0
Totale													2.056